‘Outdated information’ may have skewed efficacy data from AstraZeneca Covid vaccine trial, US govt health institute claims ...News

Russia Today - News
‘Outdated information’ may have skewed efficacy data from AstraZeneca Covid vaccine trial, US govt health institute claims
The results of a recent US trial for AstraZeneca’s Covid-19 vaccine may have used data that is no longer relevant, raising questions about accuracy, the US National Institute of Allergy and Infectious Diseases (NIAID) has said. On Monday, the pharmaceutical giant released promising interim results from its US study, which showed its drug to have 79% efficacy in stopping symptomatic Covid-19 and to be 100% effective at preventing severe cases and hospitalization. The firm also said that the results showed that the drug does not cause blood clots.  Read more EU citizens losing

Hence then, the article about outdated information may have skewed efficacy data from astrazeneca covid vaccine trial us govt health institute claims was published today ( ) and is available on Russia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( ‘Outdated information’ may have skewed efficacy data from AstraZeneca Covid vaccine trial, US govt health institute claims )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News